| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |